PROFILING PCR and BEYOND (PCR855/QGA856)
|Event Date/Time: Jun 02, 2003||End Date/Time: Jun 06, 2003|
|Registration Date: Apr 18, 2003|
|Early Registration Date: Mar 07, 2003|
|Abstract Submission Date: Apr 24, 2003|
|Paper Submission Date: Apr 24, 2003|
Nucleic acid amplification and detection have become the most widely used technique for conducting biological research. Like the genetic material being exponentially amplified utilization has exploded to an increasing range of applications including molecular biology, environmental science, forensic science, medical science, biotechnology, microbiology, the food industry, diagnostic science, epidemiology, genetics, gene cloning, and more. Microarray development continues to drive these discoveries. New technical developments that improve the performance of nucleic acid amplification and detection, as well as interesting examples of how these techniques are used, are the emphases of this meeting.
Dr. Stanley Abramowitz, Advanced Technology Group
Dr. Michael Egholm, Molecular Staging, Inc.
Mr. Shaun Lonergan, NimbleGen Systems
Overcoming the PCR Obstacle to High-Throughput DNA Analysis
Dr. Charles R. Cantor, Sequenom, Inc.
Dr. Kimimichi Obata, Precision System Science Europe GmbH
Dr. Martin Gilar, Life Sciences Chemistry, Waters Corporation
Dr. Sheng-Guo Fang, Zhejian University
Dr. William C. Okulicz, University of Massachusetts Medical School
Primers, Probes, and Detection
Dr. Quin Chou, BioSource International
Dr. Klaus-Peter Stengele, Chemogenix
Dr. George E. Fox, Professor, University of Houston
Dr. Yingfu Li, McMaster University
Dr. Todd Peterson, Genicon Sciences Corporation
Dr. Y. Paul Bao, Nanosphere Inc.
Dr. John P. Langmore, Rubicon Genomics, Inc.
Dr. Ie-Ming Shih, Johns Hopkins School of Medicine
Dr. Michael Egholm
Dr. G. Mike Makrigiorgos, Dana-Farber Cancer Institute and Harvard Medical School
Dr. James R. Prudent, EraGen Biosciences, Inc.
Dr. Chiara Mazzanti, National Institutes of Health
Dr. Bruce Seligmann, High Throughput Genomics
Dr. Michael Herrler, NuGEN Technologies, Inc.
Dr. Ren Y. Xu, Amgen Inc.
Dr. Beverly A. Brown, Linden Bioscience